Quick Summary
Mitotax 260mg Injection
Last updated on 19 Aug 2026 | 06:50 AM (IST)
₹2497
MRP: ₹9988.48
(You Save ₹7491.48)
1 VIAL(s)
75% OFF
₹2497
MRP: ₹9,988.48
Inclusive of all taxes
75% Off
Dispatch: Today
Order In: 0h 0m 0s
0h 0m 0s
Order before timer ends to ensure your medicine is dispatched at...
Substitutes
Dutaxel 260mg Injection
SAMARTH LIFE SC...
₹ 784.00/injection
68% cheaper
Kansure 260mg Injection
KHANDELWAL LABO...
₹ 863.00/injection
65% cheaper
Taxeleon 260mg Injection
NEON LABORATORI...
₹ 937.00/injection
62% cheaper
Pacliarc 260mg Injection
DELARC PHARMACE...
₹ 1125.00/injection
54% cheaper
Introduction
Mitotax 260mg Injection is a chemotherapy medication containing the active constituent paclitaxel. It is used to treat breast cancer, non-small cell lung cancer, ovarian cancer, and AIDS (Acquired Immuno-Deficiency Syndrome). Cancer is a condition in which cells are dividing and growing fast and in an uncontrolled manner. This medicine is not recommended for adolescents and children under the age of 18.
Mitotax 260mg Injection may be given alone or in combination with other anticancer medicines. This chemotherapy medication is contraindicated in patients with severe liver problems, uncontrolled infection, and low white blood cell or platelet count. Talk to your doctor if you have heart disorders before taking this medicine.
Administration of this medicine may cause serious allergic reactions. Use effective birth control during the treatment and for at least six months after the last dose. Mitotax 260mg Injection may be harmful to patients suffering from alcoholism as this medicine contains alcohol.
Uses
Mitotax 260mg Injection is used in the treatment of the following:
Ovarian cancer
Breast cancer
Non-small cell lung cancer
AIDS-related Kaposi’s sarcoma
How Mitotax 260mg Injection Works
Mitotax 260mg Injection inhibits the microtubule structures present in the cell. Microtubule structures help cancer cells to divide and multiply. Inhibition of these structures slows the growth of cancer cells.
Interaction of Mitotax 260mg Injection with other drugs
It is important to inform your healthcare professional about all the medications you are taking, including prescription drugs, over-the-counter medications, nutritional supplements, and herbal products. Some medications may interact with Mitotax 260mg Injection, potentially affecting their effectiveness or causing side effects.
Storage
Keep Mitotax 260mg Injection out of sight and reach of children.
Do not store above 25°C.
Store in the original packaging to protect from moisture.
Avoid direct sunlight
How to Use Mitotax 260mg Injection
Mitotax 260mg Injection will be administered to you intravenously by a healthcare professional or nurse in a healthcare setting. Do not self-administer this medication. For dosage adjustments or any concerns, please consult your healthcare provider.
Safety Advice
Pregnancy
Mitotax 260mg Injection can harm your unborn baby. Tell your doctor if you are pregnant or planning to get pregnant before taking Mitotax 260mg Injection.
Breast Feeding
Stop breastfeeding during the treatment with Mitotax 260mg Injection. Consult your doctor for potential risks.
Lungs
It is unknown whether Mitotax 260mg Injection can be given to patients with lung disorders. Please consult your physician for more advice.
Liver
It is contraindicated in patients with severe liver disorders. Inform your doctor if you have any liver disorders before taking Mitotax 260mg Injection
Alcohol
It is unsafe to consume alcohol with Mitotax 260mg Injection.
Driving
The alcohol present in Mitotax 260mg Injection may affect your ability to drive. Avoid driving if you feel unwell.
Side Effects
Side effects are unwanted symptoms caused by medicines. Even though all medicines cause side effects, not everyone gets them.
Serious side effects of Mitotax 260mg Injection are:
Serious allergic reactions (rash, swelling of face, lips, throat, or tongue, trouble breathing, and swallowing)
Severe diarrhoea
Severe stomach pain
Common side effects of Mitotax 260mg Injection are:
Anemia, feeling tired
Hair loss
Burning, tingling, or numbness in your feet or hands
Muscle and joint pain
Vomiting, nausea
Mouth or lip sores
Infections
Swelling of hands, feet, and face
Bleeding
Irritation at the injection site
Low blood pressure
Expert Tips
Inform your doctor if you are allergic to this medicine or have a history of liver problems, heart conditions, or if you are taking other medications for different health conditions.
Your liver function, blood pressure, and blood count should be regularly monitored during treatment.
Do not take this medication if you are pregnant, planning to become pregnant, or breastfeeding, as it may harm the baby.
Avoid driving or operating heavy machinery after taking this medicine, as it may reduce your concentration and alertness.
FAQs
Q1.
Can Mitotax 260mg Injection cause hair loss?
Yes, the common side effect of this medication is hair loss and inform the doctor if there is excessive hair loss.
Q2.
Can I take Mitotax 260mg Injection during pregnancy?
It is unsafe to take this medication during pregnancy as it causes harmful effects on the developing baby. Inform the doctor if the patient is planning for pregnancy before starting this medication.
Q3.
What are the side effects of Mitotax 260mg Injection?
The common side effects of this medication are anaemia, hair loss, numbness in feet or hands, muscle pain, nausea, vomiting, infections, swelling, bleeding, irritation on the injection site, and low blood pressure.
Q4.
What is the Working mechanism of Mitotax 260mg Injection?
Mitotax 260mg Injection works by interfering with the microtubule structures that cancer cells need to divide and grow. By disrupting this process it helps slow down the growth and spread of cancer cells.
Q5.
Can I take Mitotax 260mg Injection while driving?
It is unsafe to use this medication while driving because it can cause dizziness, lack of concentration and alertness.
Fact Box
Molecule name | Paclitaxel |
Pharmacological class | Anti-Microtubular Agents |
Therapeutic class | Anti-Neoplastics |
Indications | 1. Ovarian cancer 2. Breast cancer 3. Non-small cell lung cancer 4. AIDS-related Kaposi’s sarcoma |
References
1. Goodman & Gilman’s, The Pharmacological Basis of Therapeutics, Cytotoxic agents, 12th edition, 2011, 1707 - 1709.
2. KD Tripathi, Essentials of Medical Pharmacology, Anticancer drugs, 7th edition, 2013, 865.
3. Hospira UK Limited, Electronic medicines compendium (emc), [ Revised on March 2020] [ Accessed on 22nd June 2021], https://www.medicines.org.uk/emc/files/pil.3891.pdf
4. Bristol-Myers Squibb Company, US Food and Drug Administration, [ Revised on April 2011] [ Accessed on 22nd June 2021], https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/020262s049lbl.pdf
Disclaimer
MrMed’s primary intention is to ensure that its consumers get information that is reviewed by experts, accurate and trustworthy. The information and contents of this website are for informational purposes only. They are not intended to be a substitute for professional medical advice, diagnosis, or treatment. Please seek the advice of your doctor and discuss all your queries related to any disease or medicine. Do not disregard professional medical advice or delay in seeking it because of something you have read on MrMed. Our mission is to support, not replace, the doctor-patient relationship.
Did you find this information helpful?
Author Details
Written By
Dr Arathy J S
BDS
Reviewed By
Dr. Tejashwin Adiga
MBBS
Last updated : 19 Aug 2026 | 06:50 AM (IST)
Want to know more?
Read Our Editorial Policy
